Using standard methods, we found no significant correlation between CXCR3 splicing and survival, nor was there any differential CXCR3 splicing detected between tumor and adjacent normal tissue (Table 1) in the breast cancer (BRCA) TCGA cohort. This evidence concerns the gene CXCR3 and neoplasm.